|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.020 USD | -7.69% |
|
-3.77% | -83.33% |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 24.4M 21.13M 19.75M 18.05M 34.01M 2.33B 34.54M 232M 90.86M 1.16B 91.64M 89.64M 3.88B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 24.4M 21.13M 19.75M 18.05M 34.01M 2.33B 34.54M 232M 90.86M 1.16B 91.64M 89.64M 3.88B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.69% | ||
| 1 week | -3.77% | ||
| Current month | -8.11% | ||
| 1 month | -15.70% | ||
| 3 months | -69.09% | ||
| 6 months | -76.11% | ||
| Current year | -83.33% |
| 1 week | 1 |  | 1.25 |
| 1 month | 1 | | 1.95 |
| Current year | 1 | | 7.05 |
| 1 year | 1 | | 9.22 |
| 3 years | 1 | | 11.99 |
| 5 years | 1 | | 11.99 |
| 10 years | 1 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 01/04/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/2/26 | Fiscal year | Chief Executive Officer | 665,984 | 2.8653% | ||
| 5/1/26 | Kairos Venture Investments LLC
| Sell | Company | 280,000 | 1.2046% | |
| 27/6/25 | BIOS Capital Management LP
| Buy | Company | 71,428 | 0.3657% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.69% | -3.77% | -87.28% | - | 24.4M | |
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | |
| +0.50% | +6.20% | +34.94% | +67.83% | 55.41B | |
| +2.78% | +36.87% | +23.00% | +493.09% | 29.43B | |
| +0.69% | +18.87% | +57.08% | +5.18% | 24.12B | |
| -0.93% | +0.60% | -16.89% | -12.00% | 23.31B | |
| -0.35% | +7.91% | +44.14% | -22.61% | 18.37B | |
| +0.09% | +10.84% | +31.14% | +628.97% | 16.1B | |
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | |
| -2.05% | -3.81% | +40.40% | +150.40% | 13.12B | |
| Average | +0.23% | +8.24% | +42.55% | +201.02% | 26.77B | |
| Weighted average by Cap. | +1.71% | +11.59% | +54.96% | +163.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | USD 1.020 | -7.69% | 215,472 |
| 07/08/26 | USD 1.105 | -10.16% | 203,570 |
| 06/08/26 | USD 1.230 | +8.85% | 186,956 |
| 05/08/26 | USD 1.130 | +0.89% | 176,619 |
| 04/08/26 | USD 1.120 | +5.66% | 309,766 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.020USD
Average target price
9.978USD
Spread / Average Target
+878.19%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
